Evidence map›Paper›PMID 35397210›Full record

ArticleThe Lancet. Oncology2022

Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.

Sean McPhail, Ruth Swann, Shane A Johnson, Matthew E Barclay, Hazem Abd Elkader, Riaz Alvi, Andriana Barisic, Oliver Bucher, Gavin R C Clark, Nicola Creighton and 32 more

Open access · hybridAbstract read
In one paragraph

Article in The Lancet. Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Prediagnostic primary care consultations and imaging in emergency-diagnosed versus referred patients with lung cancer: a population-based linked data study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 6 countries.

Sean McPhailNational Disease Registration Service, NHS Digital, Leeds, UK.
Ruth SwannNational Disease Registration Service, NHS Digital, Leeds, UK; Cancer Research UK, London, UK.
Shane A JohnsonCancer Research UK, London, UK.
Matthew E BarclayEpidemiology of Cancer Healthcare and Outcomes, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care (IEHC), University College London, London, UK.
Hazem Abd ElkaderCancer Society of New Zealand, Wellington, New Zealand.
Riaz AlviDepartment of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Andriana BarisicOntario Health (Cancer Care Ontario), Toronto, ON, Canada.
Oliver BucherDepartment of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada.
Gavin R C ClarkPublic Health Scotland, Edinburgh, UK.
Nicola CreightonCancer Institute NSW, St Leonards, NSW, Australia.
Bolette DanckertDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Cheryl A DennyPublic Health Scotland, Edinburgh, UK.
David W DonnellyNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Jeff J DowdenProvincial Cancer Care Program, Eastern Health, St John's, NL, Canada.
Norah FinnVictorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia; Cancer Support, Treatment and Research, Department of Health, Melbourne, VIC, Australia.
Colin R FoxNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Sharon FungCanadian Partnership against Cancer, Toronto, ON, Canada.
Anna T GavinNorthern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Elba Gomez NavasCanadian Partnership against Cancer, Toronto, ON, Canada.
Steven HabbousOntario Health (Cancer Care Ontario), Toronto, ON, Canada.
Jihee HanCanadian Partnership against Cancer, Toronto, ON, Canada.
Dyfed W HuwsWelsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Population Data Science, Swansea University Medical School, Swansea, UK.
Christopher G C A JacksonDepartment of Medicine, Otago Medical School, University of Otago, Dunedin, New Zealand.
Henry JensenResearch Unit for General Practice, Aarhus University, Aarhus, Denmark.
Bethany KaposhiSurveillance and Reporting, Advanced Analytics, Cancer Care Alberta, Alberta Health Services, Edmonton.
S Eshwar KumarNew Brunswick Cancer Network, Department of Health, New Brunswick, Fredericton, NB, Canada.
Alana L LittleCancer Institute NSW, St Leonards, NSW, Australia.
Shuang LuCalgary, AB, Canada.
Carol A McClurePrince Edward Island Cancer Registry, Queen Elizabeth Hospital, Charlottetown, PE, Canada.
Bjørn MøllerCancer Registry of Norway, Oslo, Norway.
Grace MustoDepartment of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada.
Yngvar NilssenCancer Registry of Norway, Oslo, Norway.
Nathalie Saint-JacquesNova Scotia Health Cancer Care Program, Halifax, NS, Canada.
Sabuj SarkerDepartment of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Luc Te MarveldeVictorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia.
Rebecca S ThomasWelsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Department of the Dean, Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
Robert J S ThomasWelsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Department of the Dean, Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
Catherine S ThomsonPublic Health Scotland, Edinburgh, UK.
Ryan R WoodsCancer Control Research, BC Cancer, Vancouver, BC, Canada.
Bin ZhangHealth Analytics, Department of Health, Fredericton, NB, Canada.
Georgios LyratzopoulosNational Disease Registration Service, NHS Digital, Leeds, UK; Epidemiology of Cancer Healthcare and Outcomes, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care (IEHC), University College London, London, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.
ICBP Module 9 Emergency Presentations Working Group
Canadian Partnership Against Cancer · CAPublic Health Scotland · GBQueen's University Belfast · GBCancerCare Manitoba · CACancer Care Ontario · CACancer Institute of New South Wales · AUCancer Registry of Norway · NOSaskatchewan Cancer Agency · CAAarhus University · DKAlberta Bible College · CAAlberta Health Services · CACancer Care Nova Scotia · CACancer Council Victoria · AUCancer Research UK Technology · GBCancer Society of New Zealand · NZDanish Cancer Society · DKGovernment of New Brunswick · CAHealth PEI · CANHS Digital · GBSt. John’s Health Sciences Centre · CA

Funding

Cancer Research UK 18180Cancer Research UK C18081/A18180
6 · The paper itself

Abstract

backgroundGreater understanding of international cancer survival differences is needed. We aimed to identify predictors and consequences of cancer diagnosis through emergency presentation in different international jurisdictions in six high-income countries.

methodsUsing a federated analysis model, in this cross-sectional population-based study, we analysed cancer registration and linked hospital admissions data from 14 jurisdictions in six countries (Australia, Canada, Denmark, New Zealand, Norway, and the UK), including patients with primary diagnosis of invasive oesophageal, stomach, colon, rectal, liver, pancreatic, lung, or ovarian cancer during study periods from Jan 1, 2012, to Dec 31, 2017. Data were collected on cancer site, age group, sex, year of diagnosis, and stage at diagnosis. Emergency presentation was defined as diagnosis of cancer within 30 days after an emergency hospital admission. Using logistic regression, we examined variables associated with emergency presentation and associations between emergency presentation and short-term mortality. We meta-analysed estimates across jurisdictions and explored jurisdiction-level associations between cancer survival and the percentage of patients diagnosed as emergencies.

findingsIn 857 068 patients across 14 jurisdictions, considering all of the eight cancer sites together, the percentage of diagnoses through emergency presentation ranged from 24·0% (9165 of 38 212 patients) to 42·5% (12 238 of 28 794 patients). There was consistently large variation in the percentage of emergency presentations by cancer site across jurisdictions. Pancreatic cancer diagnoses had the highest percentage of emergency presentations on average overall (46·1% [30 972 of 67 173 patients]), with the jurisdictional range being 34·1% (1083 of 3172 patients) to 60·4% (1317 of 2182 patients). Rectal cancer had the lowest percentage of emergency presentations on average overall (12·1% [10 051 of 83 325 patients]), with a jurisdictional range of 9·1% (403 of 4438 patients) to 19·8% (643 of 3247 patients). Across the jurisdictions, older age (ie, 75-84 years and 85 years or older, compared with younger patients) and advanced stage at diagnosis compared with non-advanced stage were consistently associated with increased emergency presentation risk, with the percentage of emergency presentations being highest in the oldest age group (85 years or older) for 110 (98%) of 112 jurisdiction-cancer site strata, and in the most advanced (distant spread) stage category for 98 (97%) of 101 jurisdiction-cancer site strata with available information. Across the jurisdictions, and despite heterogeneity in association size (I

interpretationInternationally, notable proportions of patients with cancer are diagnosed through emergency presentation. Specific types of cancer, older age, and advanced stage at diagnosis are consistently associated with an increased risk of emergency presentation, which strongly predicts worse prognosis and probably contributes to international differences in cancer survival. Monitoring emergency presentations, and identifying and acting on contributing behavioural and health-care factors, is a global priority for cancer control.

fundingCanadian Partnership Against Cancer; Cancer Council Victoria; Cancer Institute New South Wales; Cancer Research UK; Danish Cancer Society; National Cancer Registry Ireland; The Cancer Society of New Zealand; National Health Service England; Norwegian Cancer Society; Public Health Agency Northern Ireland, on behalf of the Northern Ireland Cancer Registry; the Scottish Government; Western Australia Department of Health; and Wales Cancer Network.

Indexed as

Ovarian NeoplasmsRectal NeoplasmsAged, 80 and overBenchmarkingCanadaCross-Sectional StudiesFemaleHospitalsHumansPrognosisRisk FactorsState MedicineVictoria

Identifiers

PMID35397210
PMCPMC9046095
OpenAlexW4223605782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.